Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review.

Ruiz, Miguel; Cocores, Alexandra; Tosti, Antonella; Goadsby, Peter J; Monteith, Teshamae S

Ruiz, Miguel; Cocores, Alexandra; Tosti, Antonella; Goadsby, Peter J; Monteith, Teshamae S.

Afiliación

Ruiz M; Department of Biological Sciences, Florida International University, Miami, Florida, USA.
Cocores A; Department of Neurology, Division of Headache, University of Miami Miller School of Medicine, Miami, Florida, USA.
Tosti A; Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Goadsby PJ; Institute of Psychiatry, Psychology, And Neuroscience, King's College, London, UK.
Monteith TS; Department of Neurology, University of California, Los Angeles, California, USA.

Cephalalgia ; 43(2): 3331024221143538, 2023 02.

Article en En | MEDLINE | ID: mdl-36739513

Asunto(s)

Péptido Relacionado con Gen de Calcitonina; Trastornos Migrañosos; Femenino; Humanos; Anticuerpos Monoclonales; Antagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitonina; Receptores de Péptido Relacionado con el Gen de Calcitonina; Masculino

Palabras clave

CGRP; FAERS; Migraine; adverse event; alopecia; telogen effluvium

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptido Relacionado con Gen de Calcitonina / Trastornos Migrañosos Límite: Female / Humans / Male Idioma: En Revista: Cephalalgia Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google